Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Mascitelli

Showing results (141-150 of 286) with videos related to

Pageof 29
Sort By:
Annals of Internal Medicine|October 19, 2011
An update on the comparative effectiveness and safety of medications for type 2 diabetesMark R Goldstein, Luca Mascitelli
Neuroepidemiology|December 14, 2011
Is intensive cholesterol lowering detrimental in multiple sclerosis?Luca Mascitelli, Mark R Goldstein
The New England Journal of Medicine|July 15, 2011
Pioglitazone for diabetes preventionMark R Goldstein, Luca Mascitelli
JAMA Surgery|December 27, 2018
Fluoroquinolone Use and Concern About the Cerebral VasculatureMark R Goldstein, Luca Mascitelli
The American Journal of Medicine|January 22, 2013
Aspirin-associated iron loss: an anticancer mechanism even in the short term?Luca Mascitelli, Mark R Goldstein
Lancet (London, England)|May 14, 2013
Statin and exercise prescriptionLuca Mascitelli, Mark R Goldstein
International Journal of Cardiology|April 23, 2013
Iron homeostasis and cardiovascular events after acute infectionsLuca Mascitelli, Mark R Goldstein
Lancet (London, England)|November 27, 2012
Statins for people at low risk of cardiovascular diseaseLuca Mascitelli, Mark R Goldstein
Clinical Endocrinology|September 2, 2014
Statin immunomodulation and thyroid cancerLuca Mascitelli, Mark R Goldstein
Journal of the American College of Cardiology|July 29, 2017
Statin Intolerance and the Obsession With Aggressive Cholesterol Lowering to Prevent Coronary Heart DiseaseLuca Mascitelli, Mark R Goldstein
Pageof 29

Showing results (141-150 of 286) with videos related to

Sort By:
Pageof 29
Annals of Internal Medicine|October 19, 2011
An update on the comparative effectiveness and safety of medications for type 2 diabetesMark R Goldstein, Luca Mascitelli
Neuroepidemiology|December 14, 2011
Is intensive cholesterol lowering detrimental in multiple sclerosis?Luca Mascitelli, Mark R Goldstein
The New England Journal of Medicine|July 15, 2011
Pioglitazone for diabetes preventionMark R Goldstein, Luca Mascitelli
JAMA Surgery|December 27, 2018
Fluoroquinolone Use and Concern About the Cerebral VasculatureMark R Goldstein, Luca Mascitelli
The American Journal of Medicine|January 22, 2013
Aspirin-associated iron loss: an anticancer mechanism even in the short term?Luca Mascitelli, Mark R Goldstein
Lancet (London, England)|May 14, 2013
Statin and exercise prescriptionLuca Mascitelli, Mark R Goldstein
International Journal of Cardiology|April 23, 2013
Iron homeostasis and cardiovascular events after acute infectionsLuca Mascitelli, Mark R Goldstein
Lancet (London, England)|November 27, 2012
Statins for people at low risk of cardiovascular diseaseLuca Mascitelli, Mark R Goldstein
Clinical Endocrinology|September 2, 2014
Statin immunomodulation and thyroid cancerLuca Mascitelli, Mark R Goldstein
Journal of the American College of Cardiology|July 29, 2017
Statin Intolerance and the Obsession With Aggressive Cholesterol Lowering to Prevent Coronary Heart DiseaseLuca Mascitelli, Mark R Goldstein
Pageof 29